ES2087311T3 - Peptidos inductores de anticuerpos que inhiben los retrovirus del tipo hiv y anticuerpos dirigidos contra tales peptidos. - Google Patents

Peptidos inductores de anticuerpos que inhiben los retrovirus del tipo hiv y anticuerpos dirigidos contra tales peptidos.

Info

Publication number
ES2087311T3
ES2087311T3 ES91919407T ES91919407T ES2087311T3 ES 2087311 T3 ES2087311 T3 ES 2087311T3 ES 91919407 T ES91919407 T ES 91919407T ES 91919407 T ES91919407 T ES 91919407T ES 2087311 T3 ES2087311 T3 ES 2087311T3
Authority
ES
Spain
Prior art keywords
peptides
inducting
antibody
directed against
antibodies directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91919407T
Other languages
English (en)
Inventor
Luc Montagnier
Danielle Berneman
Denise Guetard
Elmostafa Bahraoui
Rietschoten Jurphaas Van
Solange Chamaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9013324A external-priority patent/FR2668488A1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Application granted granted Critical
Publication of ES2087311T3 publication Critical patent/ES2087311T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1253—Gram-negative bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A PEPTIDOS QUE CONTIENEN SECUENCIAS DE AMIOACIDOS A PARTIR DE MICOPLASMAS, PARTICULARMENTE DE LA PROTEINA MG PA DE LA ADESINA DE M-GENITALIUM, Y MAS EN PARTICULAR DE POLIPEPTIDOS QUE TIENEN UNA HOMOLOGIA DE SECUENCIA CON PROTEINAS O GLICOPROTEINAS DE HIV. UN PEPTIDO REPRESENTATIVO SE CARACTERIZA EN QUE LA SECUENCIA G V V S T P L N I N G Q. ESTOS PEPTIDOS
ES91919407T 1990-09-27 1991-09-27 Peptidos inductores de anticuerpos que inhiben los retrovirus del tipo hiv y anticuerpos dirigidos contra tales peptidos. Expired - Lifetime ES2087311T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9011951 1990-09-27
FR9013324A FR2668488A1 (fr) 1990-10-26 1990-10-26 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides.

Publications (1)

Publication Number Publication Date
ES2087311T3 true ES2087311T3 (es) 1996-07-16

Family

ID=26228256

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91919407T Expired - Lifetime ES2087311T3 (es) 1990-09-27 1991-09-27 Peptidos inductores de anticuerpos que inhiben los retrovirus del tipo hiv y anticuerpos dirigidos contra tales peptidos.

Country Status (8)

Country Link
EP (2) EP0550691B1 (es)
AT (1) ATE135407T1 (es)
CA (1) CA2092546A1 (es)
DE (1) DE69117965T2 (es)
DK (1) DK0550691T3 (es)
ES (1) ES2087311T3 (es)
GR (1) GR3020185T3 (es)
WO (1) WO1992006199A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773293A (en) * 1992-01-27 1998-06-30 Icos Corporation Anti-ICAM-4 antibodies and hybridomas
US5700658A (en) * 1992-01-27 1997-12-23 Icos Corporation ICAM-4 materials and methods
US5753502A (en) * 1993-08-05 1998-05-19 Icos Corporation Neuron-specific ICAM-4 promoter
FR2696186B1 (fr) * 1992-09-28 1994-12-02 Pasteur Institut Souches de Mycoplasma. fermentans cytopathogène et procédés de diagnostic in vitro et d'immunisation mettant en Óoeuvre de telles souches.
FR2705970B1 (fr) * 1993-06-04 1995-08-04 Pasteur Institut Identification du gène de l'adhésine de M. Pirum.
DE4430601A1 (de) * 1994-08-22 1996-02-29 Beiersdorf Ag Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander
CN1423698A (zh) 1999-11-16 2003-06-11 真那特应用生物科技有限公司 Hiv－1亚型间(c/b’)基因组和其用途
EP2905031A1 (en) * 2014-02-10 2015-08-12 B Cell Design A new non-HIV vaccine antigen from the vaginal microbiota capable of inducing a mucosal neutralizing protective antibody response against HIV infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945041A (en) * 1983-11-17 1990-07-31 Board Of Regents Monoclonal antibodies for Mycoplasma pneumoniae and use for diagnosis of pneumonia
EP0387915B1 (en) * 1984-10-18 1993-03-10 Institut Pasteur F antigens of the human immunodeficiency virus, and their applications

Also Published As

Publication number Publication date
WO1992006199A3 (fr) 1992-05-29
WO1992006199A2 (fr) 1992-04-16
CA2092546A1 (fr) 1992-03-28
DK0550691T3 (da) 1996-07-29
EP0550691B1 (fr) 1996-03-13
EP0550691A1 (fr) 1993-07-14
GR3020185T3 (en) 1996-09-30
EP0736542A1 (fr) 1996-10-09
DE69117965D1 (de) 1996-04-18
ATE135407T1 (de) 1996-03-15
DE69117965T2 (de) 1996-11-14

Similar Documents

Publication Publication Date Title
IT1242149B (it) Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
ES2059547T3 (es) Expresion y secrecion mejoradas de proteinas heterologas en levadura, empleando secuencia conductora de factor alfa truncado.
ES2192620T3 (es) Polipeptido receptor de il-13.
EA199800946A1 (ru) Концентрированный препарат антител
CL2009002139A1 (es) Peptido sintetico que comprende la secuencia sec id no:6 y sec id no:7 de la proteina gp41 del virus vih con actividad antiretroviral.
ES2124922T3 (es) Peptidos derivados de un retrovirus del grupo hiv y su uso.
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
CO4790174A1 (es) Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
DE69417252D1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
DE3583293D1 (de) Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
ATE135743T1 (de) Monoklonale menschliche antikörper gegen hiv-i
ES2194836T3 (es) Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
DE69322872D1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
EA199800692A1 (ru) Изолируемые смеси из семян eugenia jambolana lamarck, способы их получения, способ получения оксамата натрия, лекарственные средства для профилактики и лечения диабета и применение указанных смесей, их компонентов и оксамата натрия для получения этих лекарственных средств
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
IT1212508B (it) Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
ES2090324T3 (es) Vacuna anticoccidica recombinante.
ES2062521T3 (es) Peptidos sinteticos para una vacuna contra hiv-1.
ATE174625T1 (de) Rekombinante hybride porinepitope
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
ATE385805T1 (de) Neue peptide

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0550691

Country of ref document: ES